Literature DB >> 11857420

Body mass and stage of breast cancer at diagnosis.

Yadong Cui1, Maura K Whiteman, Jodi A Flaws, Patricia Langenberg, Katherine H Tkaczuk, Trudy L Bush.   

Abstract

Obesity is a well-known risk factor for postmenopausal breast cancer. In contrast, the relationship between obesity and stage of breast cancer at diagnosis is less clear. We hypothesized that increased breast size in obese women may delay discovery of breast tumors. Thus, the purpose of our study was to examine whether there is an association between body mass and stage of breast cancer at diagnosis using hospital medical records. Newly diagnosed breast cancer cases (n = 966) in the Baltimore metropolitan area from 1991 to 1997 were included in our study. Patient information including age, ethnicity, weight, height and pathology data were obtained from hospital medical records. High body mass was significantly associated with late stage of breast cancer at diagnosis. Women who were obese (body mass index [BMI] > or = 27.3) were more likely to be at an advanced stage at diagnosis compared with women with a BMI of < 27.3 (multivariate-adjusted odds ratio [OR] 1.57, 95% confidence interval [CI] 1.15-2.14). The association between body mass and stage at diagnosis was stronger among women younger than 50 years (OR 2.34, 95% CI 1.34-4.08) compared with women 50 years or older (OR 1.30, 95% CI 0.89-1.91). Our study suggests that higher body mass is associated with advanced stage of breast cancer at diagnosis. This finding may be of considerable concern, given the increasing prevalence of obesity in women in the United States and the poor prognosis associated with late-stage tumors. Copyright 2001 Wiley‐Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11857420     DOI: 10.1002/ijc.10209

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  53 in total

1.  Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Stephanie R Land; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-07

2.  Availability and utility of body mass index for population-based cancer surveillance.

Authors:  Theresa H M Keegan; Gem M Le; Laura A McClure; Sally L Glaser
Journal:  Cancer Causes Control       Date:  2007-10-18       Impact factor: 2.506

Review 3.  Obesity and breast cancer: not only a risk factor of the disease.

Authors:  Doris S M Chan; Teresa Norat
Journal:  Curr Treat Options Oncol       Date:  2015-05

4.  Industry is not the dark side, but an essential partner to make progress in reproductive health.

Authors:  Thomas D'Hooghe
Journal:  Womens Health (Lond)       Date:  2016-03-03

5.  Impact of body mass index on prognostically relevant breast cancer tumor characteristics.

Authors:  Monika Eichholzer; Dorothy J Huang; Alexandra Modlasiak; Seraina M Schmid; Andreas Schötzau; Sabine Rohrmann; Uwe Güth
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

6.  Pre and post radiotherapy serum oxidant/antioxidant status in breast cancer patients: Impact of age, BMI and clinical stage of the disease.

Authors:  Maryam Khalil Arjmandi; Dariush Moslemi; Azadeh Sadati Zarrini; Maryam Ebrahimnezhad Gorji; Abbas Mosapour; Asefeh Haghhaghighi; Sohrab Halalkhor; Ali Bijani; Hadi Parsian
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-10

7.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Authors:  James J Dignam; Kelly Wieand; Karen A Johnson; Bernard Fisher; Lei Xu; Eleftherios P Mamounas
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

8.  The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.

Authors:  Paula M Lantz; Mahasin Mujahid; Kendra Schwartz; Nancy K Janz; Angela Fagerlin; Barbara Salem; Lihua Liu; Dennis Deapen; Steven J Katz
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

9.  Family physicians' barriers to cancer screening in extremely obese patients.

Authors:  Jeanne M Ferrante; Denise C Fyffe; Marielos L Vega; Alicja K Piasecki; Pamela A Ohman-Strickland; Benjamin F Crabtree
Journal:  Obesity (Silver Spring)       Date:  2009-12-17       Impact factor: 5.002

Review 10.  The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis.

Authors:  Jessica McCready; Lisa M Arendt; Jenny A Rudnick; Charlotte Kuperwasser
Journal:  Breast Cancer Res       Date:  2010-06-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.